Live price temporarily unavailable.
Price history
Revvity (RVTY) is a Health Care company in the S&P 500. Latest news and coverage below.
About Revvity
Revvity, Inc. is a multinational company headquartered in Waltham, Massachusetts, USA, in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
Recent News (7)
-
RBC Capital initiates Revvity stock with Sector Perform rating
RBC Capital initiates Revvity stock with Sector Perform rating
-
Revvity Inc stock hits 52-week high at 130.07 USD
Revvity Inc stock hits 52-week high at 130.07 USD
-
Revvity Stock: Is Wall Street Bullish or Bearish?
Revvity Stock: Is Wall Street Bullish or Bearish?
-
Revvity stock hits 52-week high at 122.26 USD
Revvity stock hits 52-week high at 122.26 USD
-
Revvity, Inc. Q2 2026 Earnings Call Summary Revvity, Inc. Q2 2026 Earnings Call Summary
-
Revvity beats estimates, raises guidance as stock jumps
Revvity beats estimates, raises guidance as stock jumps
-
Revvity earnings beat by $0.20, revenue topped estimates
Revvity earnings beat by $0.20, revenue topped estimates
More Health Care stocks
- ABT Abbott Laboratories
- BAX Baxter International
- BDX Becton Dickinson
- BSX Boston Scientific
- DXCM Dexcom
- EW Edwards Lifesciences
- GEHC GE HealthCare
- IDXX Idexx Laboratories